At-home cardiac rehabilitation for adolescents at risk for heart failure
Run by Children's Hospital Los Angeles · NCT06826534 · Data updated 2026-11-12
This study is testing whether an at-home exercise and nutrition program can help young cancer survivors aged 10-21 improve their heart health and overall well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Years to 21 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Children's Hospital Los Angeles Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | October 20, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | February 14, 2025 |
| Trial ID | NCT06826534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 10-21 who have a history of anthracycline exposure, are currently in remission, and have limited physical activity prior to the intervention.
✕Probably not a fit
Patients with other primary medical diagnoses or contraindications to moderate activity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of an at-home cardio-oncology rehabilitation program on cardiovascular fitness and psychosocial wellness in pediatric cancer survivors aged 10-21. The study aims to evaluate the efficacy of this program, adherence rates to exercise recommendations, and the value of specific resources in promoting sustainable lifestyle changes. Participants will engage in a structured exercise regimen and dietary recommendations while receiving support from a multidisciplinary team. The hypothesis is that these interventions will lead to improved health outcomes for adolescents who have undergone treatment for cancer.
Why it matters
Potential benefit: If successful, this program could significantly enhance cardiovascular health and overall wellness in adolescent cancer survivors.
How similar studies have gone: Other studies have shown promising results with similar rehabilitation approaches in improving health outcomes for cancer survivors, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA * Patients aged of 10-21 years at enrollment * Parent/legal guardian available for consent (if applicable), and patient available for assent and consent * History of anthracycline exposure +/- radiation * Currently in remission, with at least 6 months off chemotherapy * Able to perform CPET * Baseline CPET with VO2 \<80% (at start of study, or CPET at CHLA after January 2020) * Smartphone compatible with Fitbit (own or parent/legal guardian's) * Ability to complete and send diary and Fitbit information on a weekly basis * Ability to participate in monthly virtual check-in visits * Baseline activity prior to intervention \<30min/day, 2x/week EXCLUSION CRITERIA * Inability to obtain consent/assent * Unable to accurately perform quality of life survey independently * No other primary medical diagnosis (e.g., Down Syndrome, Wolff-Parkinson-White Syndrome, congenital heart disease) or history of cardiothoracic surgery * Contraindication to moderate activity (\>3 METs). Examples include history of malignant arrhythmias, exercise-induced syncope, severe symptoms of HF (NYHA IV, ACC/AHA Stage D) * Unable to perform CPET, echocardiogram, EKG, or obtain laboratory studies * Unable to perform mild activity for at least 0.5h/day and at least 2x/week * Unable to come to hospital for study visits at 0 and 6 months * Unable to complete study-related surveys * Unable to complete and send diary and Fitbit information on a weekly basis * Unable to check-in monthly on virtual platform * On beta blockade * Pregnancy
Where it's running
-
Children's Hospital Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Jennifer Su, MD — Children's Hospital Los Angeles
- Study coordinator: Obdulio Carreras
- Email: ocarreras@chla.usc.edu
- Phone: (323) 361-4663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiovascular Outcomes After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors
This study tests how often and what kinds of cardiovascular problems occur after adrenalectomy for pheochromocytoma or non-secreting tumors.
-
Tropicamide/phenylephrine safety in hospitalized patients
This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.
-
Using dapagliflozin to reduce cardiovascular risk after hypertensive pregnancies
This study is testing if the medication dapagliflozin can help reduce heart risks for women who had high blood pressure during pregnancy after they give birth.
-
Using colchicine to reduce heart risks in patients having major non-heart surgery
This study is testing if colchicine can help lower heart risks for patients having major surgeries that aren't related to the heart.
-
Effects of exercise training in lymphoma survivors
This study is testing whether adding aerobic and resistance exercise to usual care can improve fitness and health for people who have survived lymphoma.
-
Assessing safety of combining radiotherapy with new systemic therapies for breast cancer
This study is testing if it's safe to give new breast cancer treatments together with radiation therapy to see if they can work well together for patients who need both.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.